Search

everythinglearnresearchcommunity

for

Search:↓

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Chicken feather gene mutation helps understand human hair disorders.

New tools show that in fish, NPY increases feeding and somatostatin decreases it.

Dosing time affects finasteride's effectiveness and safety in rats.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Shift work disrupts the body's natural clock, leading to health problems.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Estrogen can temporarily slow down hair growth but this can be reversed.

Deleting MED1 in skin cells causes hair loss and skin changes.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Skin symptoms can indicate endocrine disorders and have various treatments.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Finasteride effectively improves hair growth and slows hair loss in men with male pattern baldness.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Human hair protein modifications could potentially indicate heart disease risk.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.